The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Glycoprotein D, a checkpoint inhibitor of early T-cell activation, to improve immunogenicity and efficacy of an HPV-16 vaccine in preclinical studies.
 
Hildegund Ertl
Stock and Other Ownership Interests - Virion Therapeutics
Research Funding - GlaxoSmithKline (Inst); Pfizer (Inst); Spark Therapeutics (Inst); Virion Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Virion Therapeutics
 
Zhiquan Xiang
No Relationships to Disclose
 
Yan Li
Research Funding - GlaxoSmithKline (Inst); Pfizer (Inst); Spark Therapeutics (Inst); Virion Therapeutics (Inst)
 
Andrew Luber
Employment - Virion Therapeutics
Leadership - Virion Therapeutics
Stock and Other Ownership Interests - Virion Therapeutics
Travel, Accommodations, Expenses - Virion Therapeutics
Other Relationship - Virion Therapeutics
(OPTIONAL) Uncompensated Relationships - Virion Therapeutics
 
Colin Magowan
Employment - Virion Therapeutics
Leadership - Virion Therapeutics
Stock and Other Ownership Interests - Virion Therapeutics
Travel, Accommodations, Expenses - Virion Therapeutics
Other Relationship - Virion Therapeutics
 
Xiang Zhou
Research Funding - GlaxoSmithKline (Inst); Pfizer (Inst); Spark Therapeutics (Inst); Virion Therapeutics (Inst)